Table 3 of Dratviman-Storobinsky, Mol Vis 2009; 15:2326-2338. Table 3 of Dratviman-Storobinsky, Mol Vis 2009; 15:2326-2338.
Table 3. Relative area of neovascularization (in vivo measurement by ImageJ).
| Time (days) |
Model of corneal neovascularization (n=32) | Bevacizumab treated (n=57) | |||
|---|---|---|---|---|---|
| No treatment | Total (n=57) | Intraocular injection (n=37) | Sub-conjuctival injection (n=20) |
||
| Intra-cameral (n=19) | Intra-vitreal (n=18) | ||||
| 2 | 11.24±7.02 | 10.98±8.79 p=0.88 | 14.41±2.98 p=0.06 | 11.05±2.49 p=0.91 | 7.05±2.88 *p=0.012 |
| 4 | 19.70±8.96 | 14.76±8.79 *p=0.01 | 16.51±6.27 p=0.18 | 14.68±5.05 p=0.03 | 15.69±6.00 p=0.09 |
| 8 | 47.42±25.45 | 27.10±21.84 *p=0.0001 | 26.28±6.53 *p=0.005 | 23.51±6.51 *p=0.001 | 32.16±15.21 p=0.04 |
| 10 | 50.62±24.74 | 28.29±20.92 *p=0.001 | 19.86±1.23 *p=0.0004 | 24.20±14.87 p=0.02 | 39.73±14.51 P=0.27 |
| 14 | 26.98±19.90 | 10.97±10.84 *p=0.002 | 5.28±5.90 *p=0.01 | 4.16±6.43 *p=0.009 | 23.48±17.32 p=0.68 |